Informative noncompliance in endpoint trials
<p>Abstract</p> <p>Noncompliance with study medications is an important issue in the design of endpoint clinical trials. Including noncompliant patient data in an intention-to-treat analysis could seriously decrease study power. Standard methods for calculating sample size account...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2004-07-01
|
| Series: | Current Controlled Trials in Cardiovascular Medicine |
| Online Access: | http://cvm.controlled-trials.com/content/5/1/5 |